{
    "Title": "New immunomodulatory treatment protocol for canine leishmaniosis reduces parasitemia and proteinuria",
    "URL": "https://doi.org/10.1371/journal.pntd.0012712",
    "Published": "December 19, 2024",
    "Subject_Areas": [
        "Dogs",
        "Nucleotides",
        "Leishmaniasis",
        "Veterinary diseases",
        "Parasitic diseases",
        "Adverse events",
        "Immune response",
        "Drug therapy"
    ],
    "Authors": {
        "Guadalupe Miró": [
            "Animal Health Department, Veterinary School, Universidad Complutense de Madrid, Madrid Spain"
        ],
        "Sergi Segarra": [
            "R&D Bioiberica S.A.U., Esplugues de Llobregat, Spain"
        ],
        "José Joaquín Cerón": [
            "Interlab-UMU, Campus de Excelencia “Mare Nostrum”, University of Murcia, Campus Espinardo, Murcia, Spain"
        ],
        "Lluís Ferrer": [
            "Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain"
        ],
        "Laia Solano-Gallego": [
            "Departament de Medicina i Cirurgia Animals, Facultat de Veterinària, Universitat Autònoma de Barcelona, Bellaterra, Spain"
        ],
        "Laia Montell": [
            "R&D Bioiberica S.A.U., Esplugues de Llobregat, Spain"
        ],
        "Ester Costa": [
            "R&D Bioiberica S.A.U., Esplugues de Llobregat, Spain"
        ],
        "Joan Teichenne": [
            "Eurecat, Technology Centre of Catalonia, Technological Unit of Nutrition and Health, Reus, Spain"
        ],
        "Roger Mariné-Casadó": [
            "Eurecat, Technology Centre of Catalonia, Technological Unit of Nutrition and Health, Reus, Spain"
        ],
        "GALILEI trial Group": [],
        "Xavier Roura": [
            "Hospital Clínic Veterinari, Universitat Autònoma de Barcelona, Bellaterra, Spain"
        ]
    }
}